News
Gilead Sciences (NasdaqGS:GILD) recently announced a partnership with the Global Fund to supply lenacapavir for HIV ...
Note that some links may require registration or subscription. The Department of Justice said it sent more than 20 subpoenas to doctors and clinics involved with transgender medical procedures on ...
11h
allAfrica.com on MSNAfrica: Global Fund Secures Access to Breakthrough HIV Prevention Drug Lenacapavir for Low - and Middle-Income CountriesA pivotal moment in the fight to end AIDS -- ensuring lifesaving innovation reaches those who need it most, wherever they live ...
Gilead Sciences GILD.O and the Global Fund to Fight AIDS, Tuberculosis and Malaria said yesterday they had finalized plans to supply a ...
UN officials warned that if the funding is not replaced, the world will see more than 4 million AIDS-related deaths and another 6 million HIV infections by 2029 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results